Hans Lennernäs (H Lennernäs)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Endoplasmic Reticulum

Top Venues

CPT: pharmacometrics & systems pharmacology

International journal of molecular sciences

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Luna Prieto Garcia, Anna Vildhede, Pär Nordell, Christine Ahlström, Ahmed B Montaser, Tetsuya Terasaki, Hans Lennernäs, Erik Sjögren
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Luna Prieto Garcia, Anna Vildhede, Pär Nordell, Christine Ahlström, Ahmed B Montaser, Tetsuya Terasaki, Hans Lennernäs, Erik Sjögren
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Luna Prieto Garcia, Anna Vildhede, Pär Nordell, Christine Ahlström, Ahmed B Montaser, Tetsuya Terasaki, Hans Lennernäs, Erik Sjögren
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Luna Prieto Garcia, Anna Vildhede, Pär Nordell, Christine Ahlström, Ahmed B Montaser, Tetsuya Terasaki, Hans Lennernäs, Erik Sjögren
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins. CPT: pharmacometrics & systems pharmacology (2024)
Oliver Degerstedt, Paul O'Callaghan, Ada Lerma Clavero, Johan Gråsjö, Olle Eriksson, Erik Sjögren, Per Hansson, Femke Heindryckx, Johan Kreuger, Hans Lennernäs
Quantitative imaging of doxorubicin diffusion and cellular uptake in biomimetic gels with human liver tumor cells. Drug delivery and translational research (2023)
Maria-José Cano-Cebrián, David Dahlgren, Fredrik Kullenberg, Karsten Peters, Tobias Olander, Markus Sjöblom, Hans Lennernäs
Chemotherapeutics Combined with Luminal Irritants: Effects on Small-Intestinal Mannitol Permeability and Villus Length in Rats. International journal of molecular sciences 23 (3) (2022)
Luna Prieto Garcia, Anna Lundahl, Christine Ahlström, Anna Vildhede, Hans Lennernäs, Erik Sjögren
Does the choice of applied physiologically-based pharmacokinetics platform matter? A case study on simvastatin disposition and drug-drug interaction. CPT: pharmacometrics & systems pharmacology 11 (9) (2022)
Fredrik Kullenberg, Karsten Peters, C Luna-Marco, A Salomonsson, M Kopsida, Oliver Degerstedt, Markus Sjöblom, P M Hellström, Femke Heindryckx, David Dahlgren, Hans Lennernäs
The progression of doxorubicin-induced intestinal mucositis in rats. Naunyn-Schmiedeberg's archives of pharmacology (2022)
Karsten Peters, David Dahlgren, Péter Pál Egerszegi, Hans Lennernäs, Markus Sjöblom
Protective Effects of Melatonin and Misoprostol against Experimentally Induced Increases in Intestinal Permeability in Rats. International journal of molecular sciences 23 (6) (2022)
David Balgoma, Fredrik Kullenberg, Karsten Peters, David Dahlgren, Femke Heindryckx, Hans Lennernäs, Mikael Hedeland
Orthogonality in Principal Component Analysis Allows the Discovery of Lipids in the Jejunum That Are Independent of Ad Libitum Feeding. Metabolites 12 (9) (2022)
Jaafar Khaled, Maria Kopsida, Hans Lennernäs, Femke Heindryckx
Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma. Cells 11 (4) (2022)
Stefan Senekowitsch, Philipp Schick, Bertil Abrahamsson, Patrick Augustijns, Thomas Gießmann, Hans Lennernäs, Christophe Matthys, Luca Marciani, Xavier Pepin, Alan Perkins, Maximilian Feldmüller, Sarah Sulaiman, Werner Weitschies, Clive G Wilson, Maura Corsetti, Mirko Koziolek
Application of In Vivo Imaging Techniques and Diagnostic Tools in Oral Drug Delivery Research. Pharmaceutics 14 (4) (2022)
Karsten Peters, David Dahlgren, Hans Lennernäs, Markus Sjöblom
Melatonin-Activated Receptor Signaling Pathways Mediate Protective Effects on Surfactant-Induced Increase in Jejunal Mucosal Permeability in Rats. International journal of molecular sciences 22 (19) (2021)
Charlotte Ebeling Barbier, Femke Heindryckx, Hans Lennernäs
Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma. International journal of molecular sciences 22 (23) (2021)
Fredrik Kullenberg, Oliver Degerstedt, Carlemi Calitz, Nataša Pavlović, David Balgoma, Johan Gråsjö, Erik Sjögren, Mikael Hedeland, Femke Heindryckx, Hans Lennernäs
In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma. Cells 10 (7) (2021)
David Dahlgren, Maria-José Cano-Cebrián, Per M Hellström, Alkwin Wanders, Markus Sjöblom, Hans Lennernäs
Prevention of Rat Intestinal Injury with a Drug Combination of Melatonin and Misoprostol. International journal of molecular sciences 21 (18) (2020)
Ulf Holmbäck, Anders Forslund, Stefan Grudén, Göran Alderborn, Arvid Söderhäll, Per M Hellström, Hans Lennernäs
Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity. Obesity science & practice 6 (3) (2020)
David Dahlgren, Hans Lennernäs
Antibody-Drug Conjugates and Targeted Treatment Strategies for Hepatocellular Carcinoma: A Drug-Delivery Perspective. Molecules (Basel, Switzerland) 25 (12) (2020)
Li Di, Per Artursson, Alex Avdeef, Leslie Z Benet, J Brian Houston, Manfred Kansy, Edward H Kerns, Hans Lennernäs, Dennis A Smith, Kiyohiko Sugano
The Critical Role of Passive Permeability in Designing Successful Drugs. ChemMedChem 15 (20) (2020)
Philip Bransford, Jack Cook, Manish Gupta, Sebastian Haertter, Handan He, Rob Ju, Jitendra Kanodia, Hans Lennernäs, David Lindley, James E Polli, Larissa Wenning, Yunhui Wu
ICH M9 Guideline in Development on Biopharmaceutics Classification System-Based Biowaivers: An Industrial Perspective from the IQ Consortium. Molecular pharmaceutics 17 (2) (2020)
Johanna Eriksson, Helena Thörn, Erik Sjögren, Lisa Holmstén, Katarina Rubin, Hans Lennernäs
Pulmonary Dissolution of Poorly Soluble Compounds Studied in an ex Vivo Rat Lung Model. Molecular pharmaceutics 16 (7) (2019)